GO
Loading...

Myriad Hits Historic High

Thursday, 13 Jun 2013 | 3:42 PM ET

CNBC's Bertha Coombs reports shares of Myriad Genetics are hitting an all-time high after the Supreme Court ruled a naturally occurring human gene cannot be patented, but upheld key DNA patents of Myriad's BRACAnalysis test.